Literature DB >> 6286827

Genetic evidence for separate functional domains on the human adenovirus specified, 72 kd, DNA binding protein.

D F Klessig, M P Quinlan.   

Abstract

Seven mutations that affect various activities of the multifunctional DNA binding protein (DBP) encoded by human adenovirus have been physically mapped to different locations within DBP gene by marker rescue experiments. Two of these mutants (Ad5ts107 and Ad5ts125) contain a lesion which, under nonpermissive temperatures, decreases the capacity of the protein to bind single-strand DNA, blocks DNA replication, and prevents normal turn-off of viral early genes. In addition, the efficiency of transformation by the ts viruses compared to wild-type virus is increased at the nonpermissive temperature. Both ts mutations are located in the 3' half of the DBP gene (C-terminal half of DBP). In contrast, the alterations in the five host range mutants (Ad2hr400-Ad2hr403, Ad5hr404) which overcome the block to viral late mRNA synthesis in monkey cells, but have no marked effect on DNA replication or early gene expression map in the 5' half of the DBP gene. These results suggest that the 72 kd DBP of adenovirus contains at least two functionally separable domains.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286827

Source DB:  PubMed          Journal:  J Mol Appl Genet        ISSN: 0271-6801


  10 in total

1.  Association of the adenovirus DNA-binding protein with RNA both in vitro and in vivo.

Authors:  V G Cleghon; D F Klessig
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  Restricted changes in the adenovirus DNA-binding protein that lead to extended host range or temperature-sensitive phenotypes.

Authors:  D E Brough; S A Rice; S Sell; D F Klessig
Journal:  J Virol       Date:  1985-07       Impact factor: 5.103

3.  Functional analysis of the adenovirus type 5 DNA-binding protein: site-directed mutants which are defective for adeno-associated virus helper activity.

Authors:  C O Quinn; G R Kitchingman
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

4.  The function(s) provided by the adenovirus-specified, DNA-binding protein required for viral late gene expression is independent of the role of the protein in viral DNA replication.

Authors:  S A Rice; D F Klessig
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

5.  Isolation and analysis of adenovirus type 5 mutants containing deletions in the gene encoding the DNA-binding protein.

Authors:  S A Rice; D F Klessig
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

6.  Introduction, stable integration, and controlled expression of a chimeric adenovirus gene whose product is toxic to the recipient human cell.

Authors:  D F Klessig; D E Brough; V Cleghon
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

7.  Correlation of vaccine-elicited systemic and mucosal nonneutralizing antibody activities with reduced acute viremia following intrarectal simian immunodeficiency virus SIVmac251 challenge of rhesus macaques.

Authors:  Rachmat Hidajat; Peng Xiao; Qifeng Zhou; David Venzon; L Ebonita Summers; Vaniambadi S Kalyanaraman; David C Montefiori; Marjorie Robert-Guroff
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

8.  Independent, spontaneous mutants of adenovirus type 2-simian virus 40 hybrid Ad2+ND3 that grow efficiently in monkey cells possess indentical mutations in the adenovirus type 2 DNA-binding protein gene.

Authors:  C W Anderson; M M Hardy; J J Dunn; D F Klessig
Journal:  J Virol       Date:  1983-10       Impact factor: 5.103

9.  Isolation and characterization of a viable adenovirus mutant defective in nuclear transport of the DNA-binding protein.

Authors:  V Cleghon; K Voelkerding; N Morin; C Delsert; D F Klessig
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

10.  Identification of two nuclear subclasses of the adenovirus type 5-encoded DNA-binding protein.

Authors:  K Voelkerding; D F Klessig
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.